Welcia Holdings Co Ltd
TSE:3141
Welcia Holdings Co Ltd
TSE:3141
Price:
2 301.5 JPY
0.7%
Market Closed
Updated:
May 18, 2024
P/E
Price to Earnings
Price to Earnings
18
Current
22.7
Median
16.5
Industry
Lower
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=18
Market Cap
/
475.5B
Net Income
26.5B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
475.5B JPY | 18 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
75.6B Zac | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.8B Zac | 0 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.7B USD | -2.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
47.3B BRL | 44.9 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
979B JPY | 18.7 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.1B CNY | 30.4 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
82.1B MXN | 17.1 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.6B SAR | 19.7 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
26.1B CNY | 24.4 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
559.2B JPY | 22.5 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
16.9
2-Years Forward
P/E
16.1
3-Years Forward
P/E
15.1
You don't have any saved screeners yet
